144 related articles for article (PubMed ID: 8312329)
1. Strategies for prolonged survival before heart transplantation in the neonatal intensive care unit.
Emery JR
J Heart Lung Transplant; 1993; 12(6 Pt 2):S161-3. PubMed ID: 8312329
[TBL] [Abstract][Full Text] [Related]
2. Outcome of listing for heart transplantation in infants younger than six months: predictors of death and interval to transplantation. The Pediatric Heart Transplantation Study Group.
Morrow WR; Naftel D; Chinnock R; Canter C; Boucek M; Zales V; McGiffin DC; Kirklin JK
J Heart Lung Transplant; 1997 Dec; 16(12):1255-66. PubMed ID: 9436138
[TBL] [Abstract][Full Text] [Related]
3. The role of interventional cardiology in pediatric heart transplantation.
Ruiz CE; Zhang HP; Larsen RL
J Heart Lung Transplant; 1993; 12(6 Pt 2):S164-7. PubMed ID: 8312330
[TBL] [Abstract][Full Text] [Related]
4. Nursing care of the neonate receiving prostaglandin E1 therapy.
Rikard DH
Neonatal Netw; 1993 Jun; 12(4):17-22. PubMed ID: 8510622
[TBL] [Abstract][Full Text] [Related]
5. [Secondary effects of prostaglandin E1 on the management of hypoplastic left heart syndrome while waiting for heart transplantation].
Caballero S; Torre I; Arias B; Blanco D; Zabala JI; Sánchez Luna M
An Esp Pediatr; 1998 May; 48(5):505-9. PubMed ID: 9656538
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin E1-induced moderation of elevated pulmonary vascular resistance. Survival on waiting list and results of orthotopic heart transplantation.
Iberer F; Wasler A; Tscheliessnigg K; Petutschnigg B; Auer T; Müller H; Rödl S
J Heart Lung Transplant; 1993; 12(2):173-8. PubMed ID: 8476887
[TBL] [Abstract][Full Text] [Related]
7. Care of infants with hypoplastic left heart syndrome.
Smith JB; Vernon-Levett P
AACN Clin Issues Crit Care Nurs; 1993 May; 4(2):329-39. PubMed ID: 8489880
[TBL] [Abstract][Full Text] [Related]
8. Short-term survivors of pediatric heart transplantation: an autopsy study of their pulmonary vascular disease.
Collins MH; Darragh RK; Caldwell RL; Turrentine MW; Brown JW
J Heart Lung Transplant; 1995; 14(6 Pt 1):1116-25. PubMed ID: 8719459
[TBL] [Abstract][Full Text] [Related]
9. The transition from fetal to neonatal circulation: normal responses and implications for infants with heart disease.
Friedman AH; Fahey JT
Semin Perinatol; 1993 Apr; 17(2):106-21. PubMed ID: 8327901
[TBL] [Abstract][Full Text] [Related]
10. Bless the babies: one hundred fifteen late survivors of heart transplantation during the first year of life. The Loma Linda University Pediatric Heart Transplant Group.
Bailey LL; Gundry SR; Razzouk AJ; Wang N; Sciolaro CM; Chiavarelli M
J Thorac Cardiovasc Surg; 1993 May; 105(5):805-14; discussion 814-5. PubMed ID: 8487560
[TBL] [Abstract][Full Text] [Related]
11. Combined prostaglandin therapy and ductal formalin infiltration in neonatal pulmonary oligemia.
Larson JE; Fleming WH; Sarafian LB; Rogler WC; Hofschire PJ; McManus BM
J Thorac Cardiovasc Surg; 1985 Dec; 90(6):907-11. PubMed ID: 4068741
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin E1 in infants with congenital heart disease: Indian experience.
Saxena A; Sharma M; Kothari SS; Juneja R; Reddy SC; Sharma R; Bhan A; Venugopal P
Indian Pediatr; 1998 Nov; 35(11):1063-9. PubMed ID: 10216540
[TBL] [Abstract][Full Text] [Related]
13. Catheter-based interventional palliation for hypoplastic left heart syndrome.
Boucek MM; Mashburn C; Chan KC
Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu; 2005; ():72-7. PubMed ID: 15818361
[TBL] [Abstract][Full Text] [Related]
14. Posttransplantation management of the newborn and the immunosuppressive role of prostaglandin E1.
Assaad A
J Heart Lung Transplant; 1993; 12(6 Pt 2):S191-4. PubMed ID: 8312335
[TBL] [Abstract][Full Text] [Related]
15. [Neonatal cortical hyperostosis. A side effect of prolonged prostaglandin E1 infusion].
Fernández MA; Gebara E
Arch Argent Pediatr; 2011 Apr; 109(2):154-9. PubMed ID: 21465075
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandins and the management of congenital heart disease.
Taylor WJ; Alpert BS
Am Fam Physician; 1982 Dec; 26(6):127-32. PubMed ID: 6890758
[TBL] [Abstract][Full Text] [Related]
17. Ductus arteriosus dilatation by prostaglandin E1 in infants with pulmonary atresia.
Heymann MA; Rudolph AM
Pediatrics; 1977 Mar; 59(3):325-9. PubMed ID: 840551
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E1 treatment in patent ductus arteriosus dependent congenital heart defects.
Tálosi G; Katona M; Rácz K; Kertész E; Onozó B; Túri S
J Perinat Med; 2004; 32(4):368-74. PubMed ID: 15346826
[TBL] [Abstract][Full Text] [Related]
19. [Value of prostaglandin E1 in cardiac malformations in the newborn infant].
Sassolas F; Bozio A; Andre M; Jocteur-Monrozier D; Champsaur G; Normand J
Pediatrie; 1984 Jun; 39(4):245-52. PubMed ID: 6504667
[TBL] [Abstract][Full Text] [Related]
20. Use of prostaglandin E1 for maintaining the patency of the ductus arteriosus.
Noah ML
Adv Prostaglandin Thromboxane Res; 1978; 4():355-62. PubMed ID: 347914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
